drugset / Trial / NCT00350857
The Young Adult and Pediatric Bipolar Study
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To examine the safety and effectiveness of extended-release carbamazepine in the treatment of children and adolescents aged 10-17 years with acute manic or mixed bipolar I disorder.
Timeline
- Start
- 2006-07
- Primary completion
- 2007-10
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Carbamazepine | Small molecule | — | — |